Intellectual disability and bleeding diathesis due to deficient CMP–sialic acid transport

No abstract is available for this paper.

• Publication year

  2013

• Venue

  Neurology

• Publication date

  2013-08-13

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1212/WNL.0b013e3182a08f53PMID 23873973
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Congenital Disorders of Glycosylation

  2016cited by this paper
• Polysialic Acid: Versatile Modification of NCAM, SynCAM 1 and Neuropilin-2

  2013cited by this paper
• Deficits in sialylation impair podocyte maturation.

  2012cited by this paper
• Diseases of glycosylation beyond classical congenital disorders of glycosylation.

  2012cited by this paper
• Clinical and diagnostic approach in unsolved CDG patients with a type 2 transferrin pattern.

  2011cited by this paper
• A novel type of macrothrombocytopenia associated with a defect in α2,3-sialylation.

  2011cited by this paper
• Current trends in the structure-activity relationships of sialyltransferases.

  2011cited by this paper
• Plasma N-glycan profiling by mass spectrometry for congenital disorders of glycosylation type II.

  2011cited by this paper
• ST3GAL3 mutations impair the development of higher cognitive functions.

  2011cited by this paper
• A method and server for predicting damaging missense mutations

  2010cited by this paper
• The repertoire of glycan determinants in the human glycome.

  2009cited by this paper
• Sialic acid is an essential nutrient for brain development and cognition.

  2009cited by this paper
• Transferrin and apolipoprotein C-III isofocusing are complementary in the diagnosis of N- and O-glycan biosynthesis defects.

  2007cited by this paper
• Thrombocytopenia and kidney disease in mice with a mutation in the C1galt1 gene

  2006cited by this paper
• Neuroglycobiology (Molecular and cellular neurobiology)

  2006cited by this paper
• The Human Solute Carrier Gene SLC35B4 Encodes a Bifunctional Nucleotide Sugar Transporter with Specificity for UDP-Xylose and UDP-N-Acetylglucosamine*

  2005cited by this paper
• Genetic complementation reveals a novel human congenital disorder of glycosylation of type II, due to inactivation of the Golgi CMP-sialic acid transporter.

  2005influential reference
• SIFT: predicting amino acid changes that affect protein function

  2003cited by this paper
• Sialylation is essential for early development in mice

  2002cited by this paper
• Conditional control of selectin ligand expression and global fucosylation events in mice with a targeted mutation at the FX locus

  2002cited by this paper
• Congenital disorders of glycosylation.

  2001cited by this paper
• Macrothrombocytopenia with abnormal demarcation membranes in megakaryocytes and neutropenia with a complete lack of sialyl-Lewis-X antigen in leukocytes--a new syndrome?

  2001cited by this paper
• Essentials of Glycobiology

  1999cited by this paper
• The protein disulphide-isomerase family: unravelling a string of folds.

  1999cited by this paper
• Membrane Topology of the Mammalian CMP-Sialic Acid Transporter*

  1999cited by this paper
• Monoclonal antibodies for the detection of desialylation of erythrocyte membranes during haemolytic disease and haemolytic uraemic syndrome caused by the in vivo action of microbial neuraminidase

  1997cited by this paper
• Functional Expression of the Murine Golgi CMP-Sialic Acid Transporter in Saccharomyces cerevisiae *

  1997cited by this paper
• Expression cloning of the Golgi CMP-sialic acid transporter.

  1996cited by this paper
• Characterization of a cis-Golgi matrix protein, GM130

  1995cited by this paper

• CDG due to Defective Membrane Transporters: Update

  2026cites this paper
• Biosynthetic and genetic pathways related to sialic acid metabolism.

  2026cites this paper
• Sialylation in the Nervous System: Functions and Mechanisms.

  2026cites this paper
• Genome-wide CRISPR/Cas9 screen identifies host factors for Newcastle disease virus replication

  2025cites this paper
• CMP-sialic acid synthetase in Drosophila requires N-glycosylation of a noncanonical site

  2025cites this paper
• A Novel Missense Variant in Ultrarare SLC35A1-CDG Alters Cellular Glycosylation, Lipid, and Energy Metabolism Without Affecting CDG Serum Markers

  2025cites this paper
• Endothelial Slc35a1 Deficiency Causes Loss of LSEC Identity and Exacerbates Neonatal Lipid Deposition in the Liver in Mice

  2024cites this paper
• Structure–Function Relationships of the CMP-Sialic Acid Transporter through Analysis of a Pathogenic Variant in an Alternatively Spliced Functional Isoform

  2024cites this paper
• Solute Carrier Family 35 (SLC35)—An Overview and Recent Progress

  2024cites this paper
• Ablation of Intestinal Epithelial Sialylation Predisposes to Acute and Chronic Intestinal Inflammation in Mice

  2024cites this paper
• Glycosphingolipids in congenital disorders of glycosylation (CDG).

  2024cites this paper
• N-acetylneuraminate pyruvate lyase controls sialylation of muscle glycoproteins essential for muscle regeneration and function

  2023cites this paper
• Sialic acid biosynthesis pathway blockade disturbs neuronal network formation in human iPSC‐derived excitatory neurons

  2023cites this paper
• Hemostatic defects in congenital disorders of glycosylation

  2023cites this paper
• Delivery of Nucleotide Sugars to the Mammalian Golgi: A Very Well (un)Explained Story

  2022cites this paper
• An interaction between SLC35A1 and ST3Gal4 is differentially affected by CDG-causing mutations in the SLC35A1 gene.

  2022cites this paper
• Glia-neuron coupling via a bipartite sialylation pathway promotes neural transmission and stress tolerance in Drosophila

  2022cites this paper
• The promiscuous binding pocket of SLC35A1 ensures redundant transport of CDP-ribitol to the Golgi

  2021cites this paper
• Congenital Disorders of Glycosylation

  2021cites this paper
• A three-pocket model for substrate coordination and selectivity by the nucleotide sugar transporters SLC35A1 and SLC35A2

  2021influential citation
• NANS-CDG: Delineation of the Genetic, Biochemical, and Clinical Spectrum

  2021cites this paper
• Novel Insights into Selected Disease-Causing Mutations within the SLC35A1 Gene Encoding the CMP-Sialic Acid Transporter

  2020influential citation
• Measuring beta‐galactose exposure on platelets: Standardization and healthy reference values

  2020cites this paper
• Platelets and Defective N-Glycosylation

  2020cites this paper
• Congenital disorders of N-linked glycosylation

  2020cites this paper
• Slc35a1 deficiency causes thrombocytopenia due to impaired megakaryocytopoiesis and excessive platelet clearance in the liver.

  2020cites this paper
• Dissecting Total Plasma and Protein-Specific Glycosylation Profiles in Congenital Disorders of Glycosylation

  2020cites this paper
• Nucleotide Sugar Transporter SLC35 Family Structure and Function

  2019cites this paper
• Mammalian O-mannosyl glycans: Biochemistry and glycopathology

  2019cites this paper
• Structural basis for the delivery of activated sialic acid into Golgi for sialyation

  2019cites this paper
• Structural basis for mammalian nucleotide sugar transport

  2019cites this paper
• Conserved Glu-47 and Lys-50 residues are critical for UDP-N-acetylglucosamine/UMP antiport activity of the mouse Golgi-associated transporter Slc35a3

  2019cites this paper
• X-ray crystal structure of the mouse CMP-sialic acid transporter in complex with CMP-sialic acid, by lipidic cubic phase

  2019cites this paper
• Therapeutic Monosaccharides: Looking back, moving forward.

  2019cites this paper
• CDG Therapies: From Bench to Bedside

  2018cites this paper
• A mutation in the gene coding for the sialic acid transporter SLC35A1 is required for platelet life span but not proplatelet formation

  2018cites this paper
• Congenital disorders of glycosylation

  2018cites this paper
• Clinical glycomics for the diagnosis of congenital disorders of glycosylation

  2018cites this paper
• Diagnosing childhood-onset inborn errors of metabolism by next-generation sequencing

  2017cites this paper
• Sialic acid mimetics for cancer immunotherapy

  2017cites this paper
• Encephalopathy caused by novel mutations in the CMP‐sialic acid transporter, SLC35A1

  2017influential citation
• TMEM165 : un nouvel acteur de la régulation de l’homéostasie golgienne du Mn2+, impliqué dans les anomalies congénitales de la glycosylation

  2017cites this paper
• NANS-mediated synthesis of sialic acid is required for brain and skeletal development

  2016cites this paper
• Identification of the molecular origins of disease in a cohort of patients with suspected congenital disorders of glycosylation (CDG)

  2016influential citation
• Genetic defects in the hexosamine and sialic acid biosynthesis pathway.

  2016cites this paper
• A functional splice variant of the human Golgi CMP-sialic acid transporter

  2016cites this paper
• High-resolution mass spectrometry glycoprofiling of intact transferrin for diagnosis and subtype identification in the congenital disorders of glycosylation.

  2015cites this paper
• Genetic and biochemical insights into muscular dystrophy-dystroglycanopathy pathomechanisms

  2015cites this paper
• Disease mutations in CMP-sialic acid transporter SLC35A1 result in abnormal α-dystroglycan O-mannosylation, independent from sialic acid.

  2015cites this paper
• The role of the complement system in the hemolytic uremic syndrome

  2015cites this paper
• Congenital disorders of glycosylation: a concise chart of glycocalyx dysfunction.

  2015cites this paper
• Sialic Acid Glycoengineering Using an Unnatural Sialic Acid for the Detection of Sialoglycan Biosynthesis Defects and On-Cell Synthesis of Siglec Ligands.

  2015cites this paper
• Golgi post-translational modifications and associated diseases

  2015cites this paper
• Diagnostic serum glycosylation profile in patients with intellectual disability as a result of MAN1B1 deficiency.

  2014cites this paper
• Congenital disorders of glycosylation: new defects and still counting

  2014cites this paper
• Defining the phenotype and diagnostic considerations in adults with congenital disorders of N-linked glycosylation

  2014cites this paper
• Structure and function of nucleotide sugar transporters: Current progress

  2014cites this paper
• Transferrin mutations at the glycosylation site complicate diagnosis of congenital disorders of glycosylation type I

  2011cites this paper